[1] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. [2] 谢珊, 艳任鹏. 宫颈癌发病年轻化的趋势分析与相应对策[J]. 中医药管理杂志,2018,26(5):10-12. [3] Wiener H G, Klinkhamer P, Schenck U, et al. European guidelines for quality assurance in cervical cancer screening:recommendations for cytology laboratories[J]. Cytopathology, 2007, 18(2):67-78. [4] Nayyereh A, Bruce K A, Karen C Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia:a cross-sectional and population-based cohort analysis[J]. BMC Public Health, 2013, 13(1):1196-1196. [5] 潘秦镜, 李凌, 乔友林, 等. 液基细胞学筛查宫颈癌的研究[J]. 中华肿瘤杂志, 2001, 23(4):309-312. [6] Koss L G. Utility of liquid-based cytology for cervical carcinoma screening[J]. Cancer,2015, 87(2):48-55. [7] 仇事. 宫颈细胞液基薄层涂片[J]. 实用妇科内分泌电子杂志, 2019,6(31):25-26. [8] Nayar R, Wilbur D C. The Bethesda System for reporting cervical cytology:a historical perspective[J]. Acta Cytologica, 2017, 61(4-5):359-372. [9] Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer[J]. J Natl Cancer Inst, 2016, 103(19):368-383. [10] Gogtay N J, Thatte U M. Statistical evaluation of diagnostic tests (part 1):sensitivity, specificity, positive and negative predictive values[J]. J Assoc Physicians India,2017, 65(6):80-84. [11] Gao F, Lü Q Y, Zhang W, et al. Application of the reactive oxygen-based cervical exfoliated cell staining solution in clinical cervical cancer screening[J]. Wuhan Univ J Nat Sci, 2019,24(3):233-237. |